Shared on07 Aug 25Fair value Decreased 20%
Consensus analyst price targets for Canopy Growth have been revised lower primarily due to a marked slowdown in forecast revenue growth, resulting in a fair value decrease from CA$3.31 to CA$2.98. What's in the News Canopy Growth introduced its Canadian-grown 7ACRES brand in Australia, expanding its medical cannabis portfolio with high-THC sativa strains Ultra Jack and Jack Frost.
Shared on24 Apr 25
AnalystConsensusTarget has increased profit margin from 0.7% to 1.1% and decreased future PE multiple from 458.9x to 291.0x.
Shared on17 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25Fair value Increased 17%
AnalystConsensusTarget has increased discount rate from 6.7% to 7.4%.